We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+27.94%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.4B
AUM Growth
+$6.4B
(+19%)
Cap. Flow
-$900M
Cap. Flow
% of AUM
-2.23%
Top 10 Holdings %
Top 10 Hldgs %
16.03%
Holding
2,489
New
261
Increased
810
Reduced
1,082
Closed
259
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$245M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$143M |
| 3 |
3M
MMM
|
+$142M |
| 4 |
Public Service Enterprise Group
PEG
|
+$108M |
| 5 |
KeyCorp
KEY
|
+$80.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$378M |
| 2 |
Kimberly-Clark
KMB
|
+$186M |
| 3 |
Altria Group
MO
|
+$141M |
| 4 |
AbbVie
ABBV
|
+$141M |
| 5 |
Pfizer
PFE
|
+$120M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.35% |
| 2 | Technology | 19% |
| 3 | Consumer Discretionary | 10.55% |
| 4 | Financials | 9.89% |
| 5 | Communication Services | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACER
1476
DELISTED
Acer Therapeutics Inc
ACER
| $501K | ﹤0.01% |
146,097
+56,327
| +63% | +$159K |
|
1477
International Bancshares
IBOC
$4.42B
| $499K | ﹤0.01% |
15,571
+1,115
| +8% | +$32.1K |
|
1478
Beam Therapeutics
BEAM
$2.55B
| $492K | ﹤0.01% |
+17,554
| New | +$378K |
|
1479
WaFd
WAFD
$2.44B
| $490K | ﹤0.01% |
18,231
-1,997
| -10% | -$51.4K |
|
1480
LiveRamp
RAMP
$2.31B
| $486K | ﹤0.01% |
11,415
-31,627
| -73% | -$1.25M |
|
1481
Spectrum Brands
SPB
$2B
| $486K | ﹤0.01% |
+10,591
| New | +$450K |
|
|
ACOR
1482
DELISTED
Acorda Therapeutics
ACOR
| $486K | ﹤0.01% |
5,509
+1,710
| +45% | +$181K |
|
1483
Aon
AON
$63.3B
| $476K | ﹤0.01% |
2,472
-74
| -3% | -$13.8K |
|
1484
InterDigital
IDCC
$8.41B
| $476K | ﹤0.01% |
8,408
+3,958
| +89% | +$210K |
|
1485
Estee Lauder
EL
$34B
| $472K | ﹤0.01% |
2,498
-1,180
| -32% | -$211K |
|
1486
Dana Inc
DAN
$3.31B
| $471K | ﹤0.01% |
38,662
-3,449
| -8% | -$37.5K |
|
|
NXGN
1487
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $469K | ﹤0.01% |
42,729
+42,399
| +12,848% | +$439K |
|
|
LCI
1488
DELISTED
Lannett Company, Inc.
LCI
| $468K | ﹤0.01% |
16,122
+90
| +0.6% | +$2.8K |
|
1489
Ionis Pharmaceuticals
IONS
$7.68B
| $463K | ﹤0.01% |
7,856
-50,379
| -87% | -$2.8M |
|
1490
Navient
NAVI
$931M
| $463K | ﹤0.01% |
65,671
-319,144
| -83% | -$2.38M |
|
|
MRLN
1491
DELISTED
Marlin Business Services Corp
MRLN
| $461K | ﹤0.01% |
54,441
-2,383
| -4% | -$18.5K |
|
1492
EPR Properties
EPR
$4.38B
| $459K | ﹤0.01% |
13,840
-7,883
| -36% | -$234K |
|
|
IPG
1493
DELISTED
Interpublic Group of Companies
IPG
| $458K | ﹤0.01% |
26,722
-7,383
| -22% | -$122K |
|
1494
Moody's
MCO
$80.5B
| $456K | ﹤0.01% |
1,659
+4
| +0.2% | +$1.02K |
|
1495
Iovance Biotherapeutics
IOVA
$4.62B
| $450K | ﹤0.01% |
+16,397
| New | +$539K |
|
|
PINC
1496
DELISTED
Premier
PINC
| $446K | ﹤0.01% |
+13,000
| New | +$427K |
|
1497
JB Hunt Transport Services
JBHT
$22.4B
| $445K | ﹤0.01% |
3,695
+3,058
| +480% | +$329K |
|
1498
First Merchants
FRME
$2.59B
| $444K | ﹤0.01% |
16,087
-11,563
| -42% | -$309K |
|
|
JWN
1499
DELISTED
Nordstrom
JWN
| $444K | ﹤0.01% |
28,631
-122,483
| -81% | -$2.16M |
|
|
GHIVW
1500
DELISTED
Gores Holdings IV, Inc. Warrant
GHIVW
| $444K | ﹤0.01% |
+250,000
| New | +$366K |
|
Similar funds
Federated Hermes's Q2 2020 Portfolio in Review
As of Q2 2020, Federated Hermes held 2,489 positions worth $40.4B, up 19% from $34B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2020 filing shows 261 new, 810 increased, 1,082 reduced and 259 closed positions. Its largest new stake was ZoomInfo Technologies: 1,084,200 shares worth $55.3M. The largest sale was Gilead Sciences, an estimated $378M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Technology and Consumer Discretionary.
- Federated Hermes's largest Q2 2020 buy was ZoomInfo Technologies: 1,084,200 shares worth $55.3M.
- Federated Hermes added most to IBM in Q2 2020, an estimated $245M increase.
- Federated Hermes's biggest Q2 2020 reduction was Gilead Sciences, cutting an estimated $378M.
- Federated Hermes fully exited Invesco in Q2 2020, selling an estimated $62.7M.
- Federated Hermes's ten largest holdings make up 16% of its $40.4B portfolio in Q2 2020.
- Federated Hermes opened 261 new positions and closed 259 in Q2 2020.
- Federated Hermes's portfolio value rose 19% quarter-over-quarter to $40.4B.
Based on Federated Hermes's 13F filing for Q2 2020, filed 13 Aug 2020.